Peer Review History
| Original SubmissionJune 6, 2025 |
|---|
|
Dear Dr. Salandra, Your manuscript was sent to three reviewers with strong and complementary expertise. I also read the manuscript independently and I agree with their assessment. This is a well-conceived and well-written paper, however, there is room to strengthen the manuscript on several fronts. On the empirical side, each reviewer highlights very actionable aspects to make the results more robust. Please address these points carefully. Regarding the conceptual framework, the paper would benefit from a more developed background discussion on the role and use of acknowledgements in scholarly communication. In its current form, the “Related Work” section touches on central aspects but does not fully elaborate them. Expanding this section by engaging with themes such as the implicit codes of professional and normative behaviour acknowledgements follow, the variation in co- and sub-authorship practices across research domains, and the under-recognised role of acknowledgements within the reward system of science, would significantly strengthen the positioning and contribution of the paper. I provide some references below that may be helpful in this regard. Baccini, A., & Petrovich, E. (2021). Normative versus strategic accounts of acknowledgment data: The case of the top-five journals of economics. Scientometrics. https://doi.org/10.1007/s11192-021-04185-6 Cronin, B. (1995), The Scholar’s Courtesy: The Role of Acknowledgments in the Primary Communication Process, Taylor Graham, Los Angeles, CA. Díaz-Faes, A. A., & Bordons, M. (2017). Making visible the invisible through the analysis of acknowledgements in the humanities. Aslib Journal of Information Management, 69(5), 576–590. https://doi.org/10.1108/AJIM-01-2017-0008 Hyland, K. (2003), “Dissertation acknowledgments: the anatomy of a Cinderella genre”, Written Communication, Vol. 20 No. 3, pp. 242-268. Mccain, K. W. (1991). Communication, Competition, The Production and Secrecy : and Dissemination of Research-Related in Genetics Information. Science, Technology, & Human Values, 16(4), 491–516. ================================================ Please submit your revised manuscript by Nov 06 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Adrian A. Diaz-Faes, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 3. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. We will update your Data Availability statement on your behalf to reflect the information you provide. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 5. We note that there is identifying data in the Supporting Information file <S1 Figure.docx>. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws. Data sharing should never compromise participant privacy. It is therefore not appropriate to publicly share personally identifiable data on human research participants. The following are examples of data that should not be shared: -Name, initials, physical address -Ages more specific than whole numbers -Internet protocol (IP) address -Specific dates (birth dates, death dates, examination dates, etc.) -Contact information such as phone number or email address -Location data -ID numbers that seem specific (long numbers, include initials, titled “Hospital ID”) rather than random (small numbers in numerical order) Data that are not directly identifying may also be inappropriate to share, as in combination they can become identifying. For example, data collected from a small group of participants, vulnerable populations, or private groups should not be shared if they involve indirect identifiers (such as sex, ethnicity, location, etc.) that may risk the identification of study participants. Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long. Please remove or anonymize all personal information (<specific identifying information in file to be removed>), ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Please note that spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file. 6. If the academic editor or reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: The paper makes an important contribution to the study of inequalities in science, supplementing prior work on recognition in authorships and citation by gender, race, region, etc. by looking at acknowledgements. Cochrane reviews provide a good setting for looking for demographic differences in acknowledgment. You might also want to discuss more why seniority/position does not affect acknowledgement, even though it effects authorship (cf. Lissoni, et al., 2013, which you cite). Controlling for average cites is good. How about controlling for total pubs (or total in last three years) as another measure of visibility? How robust are your result to recoding the generic acknowledgements (“We acknowledge the work of the author team for the first version of the review”.) as 0 instead of 1? What happens if you add a new variable, “Acknowledges others besides prior review authors”? And see what review team variables predict this (same as what predicts dropping prior authors, but with sign reversed)? And, if you then control for this variable, does it affect your current results? This can be seen as a measure of how generous/stingy the author of the new review is, and might explain some of the drops in acknowledgements (beyond the demographics of prior authors). For the effect of length, you might want to exclude the author names from the length count, as these are mechanically correlated with the outcome (in the wrong direction). “Following Certo et al. [43], to assess the strength of our exclusion restrictions, we checked) the correlation between the key independent variables of interest in the second stage (Female and Non-White) and the Inverse Mills Ratio, as well as the pseudo-R2 associated with the first stage.“ What do the correlations show? What happens when you control for the continent of the Original Review? You report the ContinentxRace interactions in the Further Analyses. But, what is the main effect of the original review being from Asia-South America-Africa? Put differently, are the URs discriminating on the basis of race or geography? At the same time, the heterogeneity analyses about the race/gender X team characteristics is not well motivated and seems to distract from the key findings. If you can drop this, or limit to the Supplement, it might be better. Is it possible to do an analysis of just the discerning omissions? Yes, the Ns get small, but this might be informative. But, showing wholesale exclusion versus discerning exclusion can address, for example, your conjectures about UR's not knowing norms versus URs discriminating against certain types of authors. At the same time, it is an unusual setting, and so you need to strongly acknowledge the limitations on generalizability (for example, see Jabbehdari and Walsh, 2017, STHV, for field differences in non-author collaborators). Reference: Authorship Norms and Project Structures in Science S. Jabbehdari and J. P. Walsh Science, Technology, & Human Values 2017 Vol. 42 Issue 5 Pages 872-900 Reviewer #2: In this study, the authors use a corpus of approximately 2,000 Cochrane systematic reviews in medicine to investigate fairness in the attribution of credit in science, focusing in particular on the relationship between acknowledgments and formal authorship. They examine the factors that lead to omission of credit by analyzing the racial and gender characteristics of omitted contributors, and they show that geographical disparities—rather than explicit biases against specific communities—affect the likelihood of omission. I particularly appreciate the choice of the Cochrane corpus: the specific authorship and acknowledgment guidelines adopted by Cochrane enable to unpack the relationship between attribution and contribution in a way that is not possible with standard scientific publications. I also commend the substantial manual work involved in matching acknowledgees with authors and resolving ambiguities, which ensures the high quality of the dataset. I also value the authors’ attempt to measure the contribution of acknowledgees through keyword analysis. Furthermore, the discussion is broad and engaging, situating the study’s findings within the broader evolution of science toward more collective practices (e.g., citizen science) and exploring the challenges of fairly recognizing contributions in these contexts. Finally, the statistical methods used are robust. Before proceeding to publication, the following minor issues should be addressed: • Streamline the literature review to reduce overlap with the introduction. • Clarify how the authors’ profiles were retrieved from Scopus: was this done manually or via the Scopus API? • Page 9: it is unclear whether the race attribution algorithm was independently validated by manually checking a sample of authors. Is the success rate of below 75% mentioned in the text the result of this validation? • Specify how the variable Institutional Status was modeled: does it refer to the university’s position in the Times Higher Education ranking? How were cases handled where authors had multiple affiliations? • Table 1: clarify whether the reported statistics for the variables marked with “a” are log-transformed values or raw values before transformation. • On page 21, among the studies applying network analysis to acknowledgments data, it would be appropriate to mention [DOI: 10.1007/s11229-022-03515-2]. Reviewer #3: This study explores whether acknowledgements in academic publications omit deserving contributors and examines the heterogeneity of these omissions by gender and race. It raises interesting questions. I would suggest clarifying the following points to enhance the manuscript's clarity. 1. First, the paper needs to improve its formatting for better readability, ensuring that both paragraphs are aligned. 2. The authors need to clarify the significance of their findings. What can be done by discovering the differences in acknowledgements related to race and gender? Introduction 3. The authors should clarify how they determine the racial and gender identities of contributors, as well as the accuracy of the tool they use, in the introduction. 4. Emphasizing the contributions of this work is crucial; while the authors present observations and data, they should highlight the broader implications of these findings. 5. I suggest to summarizing the research questions at the end of the introduction may also enhance clarity. Related work 6. The related work section needs to be more detailed and multi-dimensional. I suggest adding subheadings to enhance logical flow and coherence. It would also be beneficial to include a section on "The Impact of Race and Gender on Acknowledgement Practices." Additionally, more references should be incorporated regarding studies that use names to identify gender or race. Also, find related research that using Cochrane dataset. Method 7. Create a framework figure to illustrate the methodological approach, aiding comprehension for readers. 8. Why was the sample date created using reviews updated as of June 2019? 9. There are 2,091 corresponding to 8,267 non-unique authors, but the same author name may appear in multiple reviews, representing different individuals. How should the issue of authors with the same name be addressed? 10. A flowchart would be beneficial to visually represent the methodological approach and decision-making process. Please include one. Result 11. How to deal with the problem of data imbalance. Asian is 0.17; White is 0.77. 12. The authors should avoid grouping multiple parts of a figure (e.g., Figure 1 A, B, C) into one and instead map distinct titles to each sub-figure for clarity. 13. The discussion section can also include subheadings. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Eugenio Petrovich Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Attribution of credit in acknowledgements: The case of systematic reviews in medicine PONE-D-25-29842R1 Dear Dr. Salandra, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Adrian A. Diaz-Faes, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Thank you for your work on the paper. You have thoroughly addressed all the comments, both in the background and empirical sections. I believe this is a well-rounded and well-positioned manuscript that should be of interest to scholars in the field of the science of science Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: The authors engaged in substantial revision and have sufficiently addressed all the comments of the editor and of the reviewers. Reviewer #2: (No Response) Reviewer #3: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: Yes: Eugenio Petrovich Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-25-29842R1 PLOS One Dear Dr. Salandra, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Adrian A. Diaz-Faes Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .